Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sepsis study aims to sharpen diagnosis in thailand

NCT ID NCT03379402

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study in Thailand looked at how well the latest sepsis definition (Sepsis-3) works for patients with community-acquired sepsis. Researchers collected blood and other samples from 1002 adults at a hospital in Ubon Ratchathani. They tracked who survived for 28 days and what germs caused the infections. The goal is to better understand sepsis in this region and improve care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could improve how doctors diagnose and treat sepsis in community settings, potentially reducing deaths.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove that any intervention works, and results may not apply outside Thailand.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,002 people

The number who actually took part.

Started

Feb 2018

Finished

Mar 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients, both males and females, presenting with sepsis will be approached for participation in the study.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Males and females 18 years old. 2. Thai nationality. 3. Required hospitalization as decided by the attending physician 4. Documented by attending physician that an infection is the primary cause of illness leading to the hospitalization. These can be infections due to any pathogens (bacteria, viruses, fungi and parasites). 5. qSOFA (quick Sepsis-related Organ Failure Assessment) score ≥ 2 defined as 2 or more of the following: * Respiratory rate ≥22 /min or required ventilator * Alteration of mental status (GCS\<15 or 10T with endotracheal tube) * Systolic blood pressure ≤100 mm Hg Exclusion Criteria: 1. Infection is not suspected to be a primary cause of the current illness episode leading to the hospitalization. For example, community-acquired sepsis is considered to be due to stroke, cardiovascular diseases, acute myocardial infarction, cancer, burn, injury, and trauma. 2. Hospitalized at the study site for this current episode for more than 24 hours before enrollment. 3. Hospitalized for this current episode for more than 72 hours at another primary/referring hospital 4. Prior to this current episode, the patient was admitted to any hospital within the last 30 days. 5. Prior to enrolment, it is documented by the attending physician that hospital acquired infection is associated with the cause of sepsis. Please note that the following conditions are not exclusion criteria, and patients with the following conditions can be enrolled into the study. * Confirmed diagnosis by any method of an infection as a major cause of illnesses leading to hospitalization. For example, a patient who already has had a definite diagnosis of malarial infection by blood smear. * Clinical diagnosis of any specific disease or any specific syndromes such as acute infective diarrhea, acute pneumonia, acute encephalomyelitis and acute myocarditis. * Suspected of having both infectious and non-infectious diseases and infectious disease is a primary cause of illnesses (primary diagnosis) leading to the hospitalization. For example, acute pneumonia with stroke as an underlying disease, etc. * Patients who are admitted to other hospitals and referred to the study site. For example a referred patient who admit to the first hospital less than 24 hours prior to enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Community-acquired infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Community-Acquired Infections infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sappasithiprasong Hospital

    Ubon Ratchathani, 34000, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.